nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Methotrexate—psoriatic arthritis	0.296	0.38	CbGbCtD
Tenofovir—ABCC4—Methotrexate—psoriatic arthritis	0.142	0.183	CbGbCtD
Tenofovir—ABCC2—Dexamethasone—psoriatic arthritis	0.105	0.135	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—psoriatic arthritis	0.0889	0.114	CbGbCtD
Tenofovir—ABCC2—Methotrexate—psoriatic arthritis	0.0846	0.109	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—psoriatic arthritis	0.0619	0.0795	CbGbCtD
Tenofovir—Hepatomegaly—Methylprednisolone—psoriatic arthritis	0.00226	0.0106	CcSEcCtD
Tenofovir—Angioedema—Auranofin—psoriatic arthritis	0.00218	0.0102	CcSEcCtD
Tenofovir—Fracture—Prednisone—psoriatic arthritis	0.00218	0.0102	CcSEcCtD
Tenofovir—Multiple fractures—Prednisone—psoriatic arthritis	0.00218	0.0102	CcSEcCtD
Tenofovir—Myopathy—Betamethasone—psoriatic arthritis	0.00207	0.0097	CcSEcCtD
Tenofovir—Myopathy—Dexamethasone—psoriatic arthritis	0.00207	0.0097	CcSEcCtD
Tenofovir—Hepatomegaly—Dexamethasone—psoriatic arthritis	0.00205	0.00961	CcSEcCtD
Tenofovir—Hepatomegaly—Betamethasone—psoriatic arthritis	0.00205	0.00961	CcSEcCtD
Tenofovir—Glycosuria—Triamcinolone—psoriatic arthritis	0.00198	0.00925	CcSEcCtD
Tenofovir—Glycosuria—Methylprednisolone—psoriatic arthritis	0.00197	0.00923	CcSEcCtD
Tenofovir—Anorexia—Auranofin—psoriatic arthritis	0.00186	0.00869	CcSEcCtD
Tenofovir—NME1—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.00185	0.254	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.00182	0.25	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.00182	0.25	CbGdCrCtD
Tenofovir—Fracture—Methotrexate—psoriatic arthritis	0.00182	0.00852	CcSEcCtD
Tenofovir—Multiple fractures—Methotrexate—psoriatic arthritis	0.00182	0.00852	CcSEcCtD
Tenofovir—Myopathy—Prednisone—psoriatic arthritis	0.0018	0.00845	CcSEcCtD
Tenofovir—Glycosuria—Dexamethasone—psoriatic arthritis	0.00179	0.00839	CcSEcCtD
Tenofovir—Glycosuria—Betamethasone—psoriatic arthritis	0.00179	0.00839	CcSEcCtD
Tenofovir—Hepatomegaly—Prednisone—psoriatic arthritis	0.00179	0.00837	CcSEcCtD
Tenofovir—NME1—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00178	0.245	CbGdCrCtD
Tenofovir—Dyspepsia—Auranofin—psoriatic arthritis	0.00171	0.00803	CcSEcCtD
Tenofovir—Decreased appetite—Auranofin—psoriatic arthritis	0.00169	0.00793	CcSEcCtD
Tenofovir—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00159	0.00746	CcSEcCtD
Tenofovir—Glycosuria—Prednisone—psoriatic arthritis	0.00156	0.00731	CcSEcCtD
Tenofovir—Abdominal pain—Auranofin—psoriatic arthritis	0.00154	0.00721	CcSEcCtD
Tenofovir—Pruritus—Auranofin—psoriatic arthritis	0.00138	0.00645	CcSEcCtD
Tenofovir—Diarrhoea—Auranofin—psoriatic arthritis	0.00133	0.00624	CcSEcCtD
Tenofovir—Vomiting—Auranofin—psoriatic arthritis	0.00124	0.0058	CcSEcCtD
Tenofovir—Rash—Auranofin—psoriatic arthritis	0.00123	0.00575	CcSEcCtD
Tenofovir—Dermatitis—Auranofin—psoriatic arthritis	0.00123	0.00574	CcSEcCtD
Tenofovir—Proteinuria—Methotrexate—psoriatic arthritis	0.0012	0.00563	CcSEcCtD
Tenofovir—Protein urine present—Methotrexate—psoriatic arthritis	0.00119	0.00556	CcSEcCtD
Tenofovir—Nausea—Auranofin—psoriatic arthritis	0.00116	0.00542	CcSEcCtD
Tenofovir—Muscular weakness—Prednisolone—psoriatic arthritis	0.00111	0.00522	CcSEcCtD
Tenofovir—Pancreatitis—Prednisolone—psoriatic arthritis	0.00107	0.00501	CcSEcCtD
Tenofovir—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00103	0.0048	CcSEcCtD
Tenofovir—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00102	0.00479	CcSEcCtD
Tenofovir—Pancreatitis—Triamcinolone—psoriatic arthritis	0.000985	0.00461	CcSEcCtD
Tenofovir—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.000983	0.0046	CcSEcCtD
Tenofovir—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.00096	0.00449	CcSEcCtD
Tenofovir—Hypokalaemia—Betamethasone—psoriatic arthritis	0.00096	0.00449	CcSEcCtD
Tenofovir—Urine output increased—Methotrexate—psoriatic arthritis	0.000956	0.00447	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000955	0.00447	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000934	0.00437	CcSEcCtD
Tenofovir—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00093	0.00435	CcSEcCtD
Tenofovir—Muscular weakness—Betamethasone—psoriatic arthritis	0.00093	0.00435	CcSEcCtD
Tenofovir—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000894	0.00418	CcSEcCtD
Tenofovir—Infestation—Methylprednisolone—psoriatic arthritis	0.000894	0.00418	CcSEcCtD
Tenofovir—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000878	0.00411	CcSEcCtD
Tenofovir—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000876	0.0041	CcSEcCtD
Tenofovir—Polyuria—Methotrexate—psoriatic arthritis	0.000874	0.00409	CcSEcCtD
Tenofovir—Sweating—Methylprednisolone—psoriatic arthritis	0.000857	0.00401	CcSEcCtD
Tenofovir—Hypokalaemia—Prednisone—psoriatic arthritis	0.000836	0.00391	CcSEcCtD
Tenofovir—Renal failure acute—Methotrexate—psoriatic arthritis	0.000831	0.00389	CcSEcCtD
Tenofovir—Weight decreased—Dexamethasone—psoriatic arthritis	0.000825	0.00386	CcSEcCtD
Tenofovir—Weight decreased—Betamethasone—psoriatic arthritis	0.000825	0.00386	CcSEcCtD
Tenofovir—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000822	0.00385	CcSEcCtD
Tenofovir—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000822	0.00385	CcSEcCtD
Tenofovir—Muscular weakness—Prednisone—psoriatic arthritis	0.00081	0.00379	CcSEcCtD
Tenofovir—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000797	0.00373	CcSEcCtD
Tenofovir—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000797	0.00373	CcSEcCtD
Tenofovir—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000788	0.00369	CcSEcCtD
Tenofovir—Pancreatitis—Prednisone—psoriatic arthritis	0.000778	0.00364	CcSEcCtD
Tenofovir—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000725	0.00339	CcSEcCtD
Tenofovir—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000723	0.00338	CcSEcCtD
Tenofovir—Weight decreased—Prednisone—psoriatic arthritis	0.000718	0.00336	CcSEcCtD
Tenofovir—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000716	0.00335	CcSEcCtD
Tenofovir—Depression—Prednisone—psoriatic arthritis	0.000706	0.0033	CcSEcCtD
Tenofovir—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000703	0.00329	CcSEcCtD
Tenofovir—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000698	0.00327	CcSEcCtD
Tenofovir—Angioedema—Prednisolone—psoriatic arthritis	0.000695	0.00326	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000694	0.00325	CcSEcCtD
Tenofovir—Back pain—Triamcinolone—psoriatic arthritis	0.000677	0.00317	CcSEcCtD
Tenofovir—Pancreatitis—Methotrexate—psoriatic arthritis	0.00065	0.00304	CcSEcCtD
Tenofovir—Angioedema—Triamcinolone—psoriatic arthritis	0.00064	0.00299	CcSEcCtD
Tenofovir—Angioedema—Methylprednisolone—psoriatic arthritis	0.000638	0.00299	CcSEcCtD
Tenofovir—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000624	0.00292	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000617	0.00289	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000601	0.00281	CcSEcCtD
Tenofovir—Myalgia—Triamcinolone—psoriatic arthritis	0.000596	0.00279	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—psoriatic arthritis	0.000595	0.00278	CcSEcCtD
Tenofovir—Myalgia—Methylprednisolone—psoriatic arthritis	0.000595	0.00278	CcSEcCtD
Tenofovir—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000595	0.00278	CcSEcCtD
Tenofovir—Anxiety—Methylprednisolone—psoriatic arthritis	0.000593	0.00277	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—psoriatic arthritis	0.000592	0.00277	CcSEcCtD
Tenofovir—Infestation—Methotrexate—psoriatic arthritis	0.000592	0.00277	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00059	0.00276	CcSEcCtD
Tenofovir—Depression—Methotrexate—psoriatic arthritis	0.00059	0.00276	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—psoriatic arthritis	0.000581	0.00272	CcSEcCtD
Tenofovir—Angioedema—Betamethasone—psoriatic arthritis	0.00058	0.00272	CcSEcCtD
Tenofovir—Angioedema—Dexamethasone—psoriatic arthritis	0.00058	0.00272	CcSEcCtD
Tenofovir—Immune system disorder—Prednisone—psoriatic arthritis	0.000574	0.00269	CcSEcCtD
Tenofovir—Sweating—Methotrexate—psoriatic arthritis	0.000567	0.00265	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—psoriatic arthritis	0.000564	0.00264	CcSEcCtD
Tenofovir—Insomnia—Prednisolone—psoriatic arthritis	0.000562	0.00263	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000559	0.00262	CcSEcCtD
Tenofovir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000559	0.00262	CcSEcCtD
Tenofovir—Mental disorder—Prednisone—psoriatic arthritis	0.000557	0.00261	CcSEcCtD
Tenofovir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000554	0.00259	CcSEcCtD
Tenofovir—Malnutrition—Prednisone—psoriatic arthritis	0.000553	0.00259	CcSEcCtD
Tenofovir—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000552	0.00259	CcSEcCtD
Tenofovir—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000551	0.00258	CcSEcCtD
Tenofovir—Myalgia—Dexamethasone—psoriatic arthritis	0.000541	0.00253	CcSEcCtD
Tenofovir—Myalgia—Betamethasone—psoriatic arthritis	0.000541	0.00253	CcSEcCtD
Tenofovir—Anxiety—Dexamethasone—psoriatic arthritis	0.000539	0.00252	CcSEcCtD
Tenofovir—Anxiety—Betamethasone—psoriatic arthritis	0.000539	0.00252	CcSEcCtD
Tenofovir—Pain—Prednisolone—psoriatic arthritis	0.000531	0.00249	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—psoriatic arthritis	0.000531	0.00249	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000524	0.00245	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—psoriatic arthritis	0.000521	0.00244	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00052	0.00244	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000519	0.00243	CcSEcCtD
Tenofovir—Insomnia—Triamcinolone—psoriatic arthritis	0.000517	0.00242	CcSEcCtD
Tenofovir—Insomnia—Methylprednisolone—psoriatic arthritis	0.000516	0.00241	CcSEcCtD
Tenofovir—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000509	0.00238	CcSEcCtD
Tenofovir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000508	0.00238	CcSEcCtD
Tenofovir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000508	0.00238	CcSEcCtD
Tenofovir—Angioedema—Prednisone—psoriatic arthritis	0.000505	0.00237	CcSEcCtD
Tenofovir—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000503	0.00235	CcSEcCtD
Tenofovir—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000502	0.00235	CcSEcCtD
Tenofovir—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000501	0.00235	CcSEcCtD
Tenofovir—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000501	0.00235	CcSEcCtD
Tenofovir—Anorexia—Dexamethasone—psoriatic arthritis	0.000494	0.00231	CcSEcCtD
Tenofovir—Anorexia—Betamethasone—psoriatic arthritis	0.000494	0.00231	CcSEcCtD
Tenofovir—Fatigue—Triamcinolone—psoriatic arthritis	0.000493	0.00231	CcSEcCtD
Tenofovir—Fatigue—Methylprednisolone—psoriatic arthritis	0.000491	0.0023	CcSEcCtD
Tenofovir—Pain—Triamcinolone—psoriatic arthritis	0.000489	0.00229	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—psoriatic arthritis	0.00048	0.00225	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000479	0.00224	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000472	0.00221	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000472	0.00221	CcSEcCtD
Tenofovir—Arthralgia—Prednisone—psoriatic arthritis	0.000471	0.0022	CcSEcCtD
Tenofovir—Myalgia—Prednisone—psoriatic arthritis	0.000471	0.0022	CcSEcCtD
Tenofovir—Anxiety—Prednisone—psoriatic arthritis	0.000469	0.0022	CcSEcCtD
Tenofovir—Insomnia—Betamethasone—psoriatic arthritis	0.000469	0.00219	CcSEcCtD
Tenofovir—Insomnia—Dexamethasone—psoriatic arthritis	0.000469	0.00219	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000468	0.00219	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000466	0.00218	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—psoriatic arthritis	0.000465	0.00218	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—psoriatic arthritis	0.000462	0.00216	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000458	0.00214	CcSEcCtD
Tenofovir—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000456	0.00214	CcSEcCtD
Tenofovir—Dyspepsia—Betamethasone—psoriatic arthritis	0.000456	0.00214	CcSEcCtD
Tenofovir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000452	0.00211	CcSEcCtD
Tenofovir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000451	0.00211	CcSEcCtD
Tenofovir—Decreased appetite—Betamethasone—psoriatic arthritis	0.000451	0.00211	CcSEcCtD
Tenofovir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000451	0.00211	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000448	0.00209	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000448	0.00209	CcSEcCtD
Tenofovir—Back pain—Methotrexate—psoriatic arthritis	0.000447	0.00209	CcSEcCtD
Tenofovir—Fatigue—Dexamethasone—psoriatic arthritis	0.000447	0.00209	CcSEcCtD
Tenofovir—Fatigue—Betamethasone—psoriatic arthritis	0.000447	0.00209	CcSEcCtD
Tenofovir—Pain—Dexamethasone—psoriatic arthritis	0.000443	0.00207	CcSEcCtD
Tenofovir—Pain—Betamethasone—psoriatic arthritis	0.000443	0.00207	CcSEcCtD
Tenofovir—Nervous system disorder—Prednisone—psoriatic arthritis	0.000443	0.00207	CcSEcCtD
Tenofovir—Skin disorder—Prednisone—psoriatic arthritis	0.000438	0.00205	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000436	0.00204	CcSEcCtD
Tenofovir—Anorexia—Prednisone—psoriatic arthritis	0.00043	0.00201	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000424	0.00198	CcSEcCtD
Tenofovir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000424	0.00198	CcSEcCtD
Tenofovir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000421	0.00197	CcSEcCtD
Tenofovir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00042	0.00197	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000411	0.00193	CcSEcCtD
Tenofovir—Dizziness—Prednisolone—psoriatic arthritis	0.000411	0.00192	CcSEcCtD
Tenofovir—Asthenia—Triamcinolone—psoriatic arthritis	0.00041	0.00192	CcSEcCtD
Tenofovir—Abdominal pain—Betamethasone—psoriatic arthritis	0.00041	0.00192	CcSEcCtD
Tenofovir—Body temperature increased—Betamethasone—psoriatic arthritis	0.00041	0.00192	CcSEcCtD
Tenofovir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00041	0.00192	CcSEcCtD
Tenofovir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00041	0.00192	CcSEcCtD
Tenofovir—Asthenia—Methylprednisolone—psoriatic arthritis	0.000409	0.00191	CcSEcCtD
Tenofovir—Insomnia—Prednisone—psoriatic arthritis	0.000408	0.00191	CcSEcCtD
Tenofovir—Pruritus—Triamcinolone—psoriatic arthritis	0.000404	0.00189	CcSEcCtD
Tenofovir—Pruritus—Methylprednisolone—psoriatic arthritis	0.000403	0.00189	CcSEcCtD
Tenofovir—Dyspepsia—Prednisone—psoriatic arthritis	0.000397	0.00186	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—psoriatic arthritis	0.000394	0.00184	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—psoriatic arthritis	0.000394	0.00184	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—psoriatic arthritis	0.000394	0.00184	CcSEcCtD
Tenofovir—Decreased appetite—Prednisone—psoriatic arthritis	0.000392	0.00184	CcSEcCtD
Tenofovir—Rash—Prednisolone—psoriatic arthritis	0.000392	0.00183	CcSEcCtD
Tenofovir—Dermatitis—Prednisolone—psoriatic arthritis	0.000391	0.00183	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000391	0.00183	CcSEcCtD
Tenofovir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00039	0.00183	CcSEcCtD
Tenofovir—Fatigue—Prednisone—psoriatic arthritis	0.000389	0.00182	CcSEcCtD
Tenofovir—Headache—Prednisolone—psoriatic arthritis	0.000389	0.00182	CcSEcCtD
Tenofovir—Dizziness—Triamcinolone—psoriatic arthritis	0.000378	0.00177	CcSEcCtD
Tenofovir—Dizziness—Methylprednisolone—psoriatic arthritis	0.000377	0.00176	CcSEcCtD
Tenofovir—Asthenia—Dexamethasone—psoriatic arthritis	0.000372	0.00174	CcSEcCtD
Tenofovir—Asthenia—Betamethasone—psoriatic arthritis	0.000372	0.00174	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00037	0.00173	CcSEcCtD
Tenofovir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000369	0.00173	CcSEcCtD
Tenofovir—Nausea—Prednisolone—psoriatic arthritis	0.000369	0.00173	CcSEcCtD
Tenofovir—Pruritus—Dexamethasone—psoriatic arthritis	0.000367	0.00172	CcSEcCtD
Tenofovir—Pruritus—Betamethasone—psoriatic arthritis	0.000367	0.00172	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—psoriatic arthritis	0.000366	0.00172	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000365	0.00171	CcSEcCtD
Tenofovir—Vomiting—Triamcinolone—psoriatic arthritis	0.000363	0.0017	CcSEcCtD
Tenofovir—Vomiting—Methylprednisolone—psoriatic arthritis	0.000362	0.0017	CcSEcCtD
Tenofovir—Rash—Triamcinolone—psoriatic arthritis	0.00036	0.00169	CcSEcCtD
Tenofovir—Dermatitis—Triamcinolone—psoriatic arthritis	0.00036	0.00168	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—psoriatic arthritis	0.00036	0.00168	CcSEcCtD
Tenofovir—Rash—Methylprednisolone—psoriatic arthritis	0.000359	0.00168	CcSEcCtD
Tenofovir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000359	0.00168	CcSEcCtD
Tenofovir—Headache—Triamcinolone—psoriatic arthritis	0.000358	0.00168	CcSEcCtD
Tenofovir—Headache—Methylprednisolone—psoriatic arthritis	0.000357	0.00167	CcSEcCtD
Tenofovir—Body temperature increased—Prednisone—psoriatic arthritis	0.000357	0.00167	CcSEcCtD
Tenofovir—Abdominal pain—Prednisone—psoriatic arthritis	0.000357	0.00167	CcSEcCtD
Tenofovir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000355	0.00166	CcSEcCtD
Tenofovir—Diarrhoea—Betamethasone—psoriatic arthritis	0.000355	0.00166	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000344	0.00161	CcSEcCtD
Tenofovir—Dizziness—Dexamethasone—psoriatic arthritis	0.000343	0.0016	CcSEcCtD
Tenofovir—Dizziness—Betamethasone—psoriatic arthritis	0.000343	0.0016	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—psoriatic arthritis	0.000341	0.0016	CcSEcCtD
Tenofovir—Nausea—Triamcinolone—psoriatic arthritis	0.000339	0.00159	CcSEcCtD
Tenofovir—Nausea—Methylprednisolone—psoriatic arthritis	0.000339	0.00158	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—psoriatic arthritis	0.000336	0.00157	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisone—psoriatic arthritis	0.000333	0.00156	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—psoriatic arthritis	0.000332	0.00155	CcSEcCtD
Tenofovir—Vomiting—Dexamethasone—psoriatic arthritis	0.00033	0.00154	CcSEcCtD
Tenofovir—Vomiting—Betamethasone—psoriatic arthritis	0.00033	0.00154	CcSEcCtD
Tenofovir—Decreased appetite—Methotrexate—psoriatic arthritis	0.000328	0.00154	CcSEcCtD
Tenofovir—Rash—Dexamethasone—psoriatic arthritis	0.000327	0.00153	CcSEcCtD
Tenofovir—Rash—Betamethasone—psoriatic arthritis	0.000327	0.00153	CcSEcCtD
Tenofovir—Dermatitis—Dexamethasone—psoriatic arthritis	0.000327	0.00153	CcSEcCtD
Tenofovir—Dermatitis—Betamethasone—psoriatic arthritis	0.000327	0.00153	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000326	0.00152	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—psoriatic arthritis	0.000325	0.00152	CcSEcCtD
Tenofovir—Headache—Betamethasone—psoriatic arthritis	0.000325	0.00152	CcSEcCtD
Tenofovir—Headache—Dexamethasone—psoriatic arthritis	0.000325	0.00152	CcSEcCtD
Tenofovir—Asthenia—Prednisone—psoriatic arthritis	0.000324	0.00152	CcSEcCtD
Tenofovir—Pain—Methotrexate—psoriatic arthritis	0.000323	0.00151	CcSEcCtD
Tenofovir—Pruritus—Prednisone—psoriatic arthritis	0.000319	0.00149	CcSEcCtD
Tenofovir—Diarrhoea—Prednisone—psoriatic arthritis	0.000309	0.00145	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000308	0.00144	CcSEcCtD
Tenofovir—Nausea—Betamethasone—psoriatic arthritis	0.000308	0.00144	CcSEcCtD
Tenofovir—Nausea—Dexamethasone—psoriatic arthritis	0.000308	0.00144	CcSEcCtD
Tenofovir—Dizziness—Prednisone—psoriatic arthritis	0.000299	0.0014	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000298	0.0014	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—psoriatic arthritis	0.000298	0.0014	CcSEcCtD
Tenofovir—Vomiting—Prednisone—psoriatic arthritis	0.000287	0.00134	CcSEcCtD
Tenofovir—Rash—Prednisone—psoriatic arthritis	0.000285	0.00133	CcSEcCtD
Tenofovir—Dermatitis—Prednisone—psoriatic arthritis	0.000284	0.00133	CcSEcCtD
Tenofovir—Headache—Prednisone—psoriatic arthritis	0.000283	0.00132	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000278	0.0013	CcSEcCtD
Tenofovir—Asthenia—Methotrexate—psoriatic arthritis	0.000271	0.00127	CcSEcCtD
Tenofovir—Nausea—Prednisone—psoriatic arthritis	0.000268	0.00126	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—psoriatic arthritis	0.000267	0.00125	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—psoriatic arthritis	0.000258	0.00121	CcSEcCtD
Tenofovir—Dizziness—Methotrexate—psoriatic arthritis	0.000249	0.00117	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—psoriatic arthritis	0.00024	0.00112	CcSEcCtD
Tenofovir—Rash—Methotrexate—psoriatic arthritis	0.000238	0.00111	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—psoriatic arthritis	0.000238	0.00111	CcSEcCtD
Tenofovir—Headache—Methotrexate—psoriatic arthritis	0.000236	0.00111	CcSEcCtD
Tenofovir—Nausea—Methotrexate—psoriatic arthritis	0.000224	0.00105	CcSEcCtD
